<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191208045652N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-11</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of dry needling in subjects with fibromyalgia with low back pain</public_title>
      <acronym></acronym>
      <scientific_title>The effect of dry needling on pain intensity, pressure pain threshold, remote muscle performance and disability in subjects with fibromyalgia and chronic nonspecific low back pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66586</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random allocation is done by block method, blocks of 4 letters consisting of letters A and B are randomly selected. Blocks are created by Random Number Generator and their sequence is specified. The letter A represents the intervention group and the letter B represents the control group. A random sequence of random blocks is then generated. Referral buying companies are placed in one of two intervention or control groups with the help of this random sequence. The person who generates the randomization sequence will not participate in any other phase of the study, Blinding description: In this study, the method of blinding the examiner will be used. The examiner of the results of the study, who is a physiotherapist with a history of examination, is not aware of the allocation of groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Fibromyalgia. Condition 2: Chronic Nonspecific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Performing dry needling technique for lumbar multifidus, quadratus lumborum and gluteus medius. In order to apply dry needling to the lumbar multifidus muscle, the patient is placed in the prone position. The muscle is palpated flat next to the vertebral spines (about one centimeter outside the spines). This area is considered as a safe area for dry needling the multifidus muscle when the needle is applied in this area and inward and downward towards the lamina of the vertebra. Based on the size of the patient, a 40 or 50 mm needle is used. To apply dry needling to the quadratus lumborum muscle, the patient lies on the side of the non-involved side. Lumbar spine, twelfth rib and iliac crest are identified. The needle is applied from the outer side of the transverse process of the lumbar vertebrae directly down, and in order to avoid the risk of damage to the kidney, we will not go higher than the level of the transverse appendage of the second lumbar vertebra. Generally, a needle with a length of 50 to 60 mm is suitable. Also, in order to apply dry needling to the gluteus medius muscle, the patient lies in the prone position and the muscle is needled with a flat touch along the iliac crest. The tissue is pressed to reduce the distance between the skin and the desired muscle. The size of the needle varies based on the amount of fat tissue present. In fact, in the middle third of the distance between the upper anterior articular spine and the upper posterior articular spine is the needle application area. The examiner first washes his hands with soap and after drying them uses sterile latex gloves. According to the recommendation of the National Acupuncture Foundation, before applying the needles, the surface of the patient's skin will be disinfected with 70% isopropyl alcohol. The needles used are sterile and disposable and their size is selected according to the size of the patient, the target muscle and the desired penetration depth. The needles are TONY brand made in China. The dry needling technique is performed by a physiotherapist who has an official dry needling certificate from the Iranian Physiotherapy Association. The dry needling method in this study will be based on the method provided by César Fernández-de-las-Peñas Jan Dommerholt. The needles are applied in order to obtain a local contraction response and this process continues until no more local contraction occurs. Finally, the needles are removed from the tissue and the position is cleaned again with cotton soaked in alcohol. Intervention 2: Control group: Patients in both groups will receive Pharmacotherapy  under the supervision of a rheumatologist, and people in the experimental group will also receive dry needling intervention. For ethical considerations, after completing the plan and measuring the results, the patients in the control group will also receive dry needling.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoume Matin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan Dormitory, Madadkaran street, Shahid Shahnazari street, Madar square, Mirdamad boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2225 6434</telephone>
        <email>mmatin.pt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzieh Yassin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physical therapy department, Rasoul Akram hospital, Niayesh street, Sattarkhan street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 2222 8052</telephone>
        <email>m.yassin.pt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People aged 18 to 65
Fibromyalgia diagnosed by a rheumatologist
The pain should be between the edge of the 12th rib and the lower gluteal fold
The duration of pain is more than three months
The minimum Visual analogue scale at the time of visit should be 3 out of 10
Patients have trigger points in the multifidus, quadratus lumborum and gluteus medius muscles
Have a minimum Oswestry Disability Index score of 20 out of 100
The participants should be able to understand and read Persian language in order to fill the questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Spinal and pelvic pathologies such as fracture, infection and tumor
Presence of systemic infection
Coagulation and bleeding disorders
Presence of lymphedema or removal of lymph nodes
pregnancy
The presence of a pacemaker
Severe respiratory and cardiovascular disorders
epilepsy
History of trauma to the lumbopelvic region
History of surgery in the lumbopelvic region
Lumbar radiculopathy
Dry needling treatment in the last 6 months
Cognitive impairment
Needle phobia
Uncontrolled diabetes
Systemic joint disease such as rheumatoid arthritis
Symptoms of radiculopathy and pressure on the nerve root
Cauda equina‏ syndrome
Spondyloarthropathies
Metal pins or prosthetic joints
Inability to communicate with the patient</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M79.7</hc_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Fibromyalgia</hc_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Performing dry needling technique for lumbar multifidus, quadratus lumborum and gluteus medius. In order to apply dry needling to the lumbar multifidus muscle, the patient is placed in the prone position. The muscle is palpated flat next to the vertebral spines (about one centimeter outside the spines). This area is considered as a safe area for dry needling the multifidus muscle when the needle is applied in this area and inward and downward towards the lamina of the vertebra. Based on the size of the patient, a 40 or 50 mm needle is used. To apply dry needling to the quadratus lumborum muscle, the patient lies on the side of the non-involved side. Lumbar spine, twelfth rib and iliac crest are identified. The needle is applied from the outer side of the transverse process of the lumbar vertebrae directly down, and in order to avoid the risk of damage to the kidney, we will not go higher than the level of the transverse appendage of the second lumbar vertebra. Generally, a needle with a length of 50 to 60 mm is suitable. Also, in order to apply dry needling to the gluteus medius muscle, the patient lies in the prone position and the muscle is needled with a flat touch along the iliac crest. The tissue is pressed to reduce the distance between the skin and the desired muscle. The size of the needle varies based on the amount of fat tissue present. In fact, in the middle third of the distance between the upper anterior articular spine and the upper posterior articular spine is the needle application area. The examiner first washes his hands with soap and after drying them uses sterile latex gloves. According to the recommendation of the National Acupuncture Foundation, before applying the needles, the surface of the patient's skin will be disinfected with 70% isopropyl alcohol. The needles used are sterile and disposable and their size is selected according to the size of the patient, the target muscle and the desired penetration depth. The needles are TONY brand made in China. The dry needling technique is performed by a physiotherapist who has an official dry needling certificate from the Iranian Physiotherapy Association. The dry needling method in this study will be based on the method provided by César Fernández-de-las-Peñas Jan Dommerholt. The needles are applied in order to obtain a local contraction response and this process continues until no more local contraction occurs. Finally, the needles are removed from the tissue and the position is cleaned again with cotton soaked in alcohol</i_keyword>
      <i_keyword>Control group: Patients in both groups will receive Pharmacotherapy  under the supervision of a rheumatologist, and people in the experimental group will also receive dry needling intervention. For ethical considerations, after completing the plan and measuring the results, the patients in the control group will also receive dry needling</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: The first session before treatment, the fourth session before the start of the treatment, the sixth session before the start of the treatment, one month after the last treatment session, three months after the last treatment session. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Muscle performance. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: dynamometer and Isometric test of neck flexor muscles.</sec_outcome>
      <sec_outcome>Pressure pain threshold. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: Algometer.</sec_outcome>
      <sec_outcome>Functional disability. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: Oswestry disability index.</sec_outcome>
      <sec_outcome>Central sensitization. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: fibromyalgia 2011 questionnaire, Algometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-10-24</approval_date>
        <contact_name>Ethics committee of Iran university of medical sciences</contact_name>
        <contact_address>Iran university of medical sciences, next to Milad tower, Hemmat highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
